DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCorporate Action

Gland Pharma Limited — Shareholders meeting

NSE 2 hrs ago·6 Nov 2026, 4:59 pm

Gland Pharma

Gland Pharma Limited has submitted the postal ballot scrutinizer's report and voting results to the stock exchange. This update confirms the official outcome of the shareholder meeting held to approve specific corporate matters.

For investors, this filing is a procedural milestone that validates the decisions made during the meeting. It signals that the company has successfully completed the necessary formalities to implement the approved resolutions, ensuring transparency in the process.

Investors should monitor the company's future announcements to see when these approved resolutions will be officially implemented. The successful completion of this voting process is a positive step toward executing the company's strategic plans.